NovaBridge Biosciences (NBP) Research & Development (2019 - 2025)
NovaBridge Biosciences (NBP) reported Research & Development of $55.7 million for Q4 2025, up 823.02% year-over-year from $6.0 million in Q4 2024, and up 391.77% quarter-over-quarter from $11.3 million in Q3 2025.
NovaBridge Biosciences (NBP) Research & Development (2019 - 2025) Analysis & Trends
NovaBridge Biosciences (NBP) has 6 years of Research & Development data on file, last reported at $55.7 million in Q4 2025.
- Research & Development for Q4 2025 came in at $55.7 million, up 823.02% year-over-year; the trailing twelve-month figure through Dec 2025 was $62.9 million (up 747.84% YoY), and the FY2025 annual result was $62.9 million, up 188.95% from the prior year.
- Research & Development improved to $55.7 million in Q4 2025 per NBP's latest filing, from $11.3 million in the prior quarter.
- Over five years, Research & Development peaked at $55.7 million in Q4 2025 and troughed at -$6.1 million in Q1 2024.
- A 4-year average of $9.2 million and a median of -$2.0 million in 2025 frame the typical range for Research & Development.
- The sharpest annual moves came in 2024 and 2025: Research & Development tumbled 82.64% in 2024, then soared 823.02% in 2025.
- A 4-year view of Research & Development shows it stood at $31.7 million in 2022, then advanced by 9.67% to $34.7 million in 2023, then plunged by 82.64% to $6.0 million in 2024, then soared by 823.02% to $55.7 million in 2025.
- Business Quant data shows NBP's Research & Development at $55.7 million in Q4 2025, $11.3 million in Q3 2025, and -$3.3 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | 4.32 Mn |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | 15.66 Mn |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 626,092.00 |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | -101.30 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | 1.46 Mn |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | -2.30 Mn |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | 357,444.00 |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 961.60 Mn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -58.00 Mn |
| 10 | NovaBridge Biosciences | 328.19 Mn | 117.34 Mn | - | 55.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 55.66 Mn |
| Sep 30, 2025 | 11.32 Mn |
| Jun 30, 2025 | -3.29 Mn |
| Mar 31, 2025 | -777,000.00 |
| Dec 31, 2024 | 6.03 Mn |
| Sep 30, 2024 | -4.48 Mn |
| Jun 30, 2024 | -5.20 Mn |
| Mar 31, 2024 | -6.06 Mn |
| Dec 31, 2023 | 34.73 Mn |
| Sep 30, 2023 | -5.09 Mn |
| Jun 30, 2023 | -4.29 Mn |
| Dec 31, 2022 | 31.67 Mn |
| Dec 31, 2020 | 332.17 Mn |
| Sep 30, 2020 | -100.85 Mn |
| Dec 31, 2019 | 201.30 Mn |
| Sep 30, 2019 | -44.70 Mn |